Product Information
DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.3445 per EA under NDC 16714080501. Its NADAC has been published 406 times since Nov 14, 2018.
FDA first approved this application on Sep 9, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAM 12.5 MG TAB
Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfateStrength
3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1
Manufacturer
NorthStar Rx LLCNDC
16714080501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040480FDA Approved
9/9/2003
TE Code
AB
On Market Since
9/9/2003
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 406 times since Nov 14, 2018, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3445 per EA |
|---|---|
| All-time high | $0.8446 (Feb 12, 2020) |
| All-time low | $0.2862 (Nov 20, 2024) |
| 52-week high | $0.4268 |
| 52-week low | $0.3065 |
| Median price | $0.5500 |
| Average price | $0.5534 |
| Largest weekly change | +70.2% (Dec 21, 2022) |
| Weeks tracked | 406 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by NorthStar Rx LLC, is $0.3445 per EA (NDC 16714080501), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 38.2%. It has been tracked across 406 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?
Since Nov 14, 2018, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.8446 (Feb 12, 2020), with a median of $0.5500 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?
DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 16714080501) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.